HDAC6 is required for invadopodia activity and invasion by breast tumor cells

被引:77
|
作者
Rey, Mercedes [1 ,2 ]
Irondelle, Marie [1 ,2 ]
Waharte, Francois [1 ,3 ]
Lizarraga, Floria [1 ,2 ]
Chavrier, Philippe [1 ,2 ]
机构
[1] Inst Curie, Res Ctr, F-75248 Paris 05, France
[2] CNRS, UMR144, F-75248 Paris 05, France
[3] Inst Curie, CNRS, Cell & Tissue Imaging Facil, PICT IBiSA,UMR 144, F-75248 Paris 05, France
关键词
Invadopodia; Acetylation; Histone deacetylase; HDAC6; Tumor cell invasion; EXTRACELLULAR-MATRIX DEGRADATION; IN-VIVO; BASEMENT-MEMBRANE; CONTACT SITES; CANCER; ACETYLATION; CORTACTIN; METALLOPROTEINASE; MICROTUBULES; DEACETYLASE;
D O I
10.1016/j.ejcb.2010.09.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Invasion across tissue boundaries by metastatic tumor cells depends on the proteolytic degradation of the extracellular matrix, initiated by the formation of invadopodia, actin-driven membrane protrusions with matrix-degradative activity. Yet, mechanisms underlying invadopodia formation remain largely unknown. In this report, we examined the role of the histone deacetylase HDAC6 in invadopodia formation and invasion by breast cancer cells. Using small interfering RNA silencing of protein expression in highly invasive MDA-MB-231 breast adenocarcinoma cells, we show that HDAC6 is required for two-dimensional matrix proteolysis. In addition, we demonstrate that HDAC6 acts as a tubulin and cortactin deacetylase. We also report that the inhibition of HDAC6 by siRNA or treatment with HDAC inhibitor TSA results in a decreased invasion capacity of a three-dimensional type I collagen matrix by MDA-MB-231 cells. These data identify HDAC6 as a critical component of the invasive apparatus of tumor cells, in both two- and three-dimensional matrices. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [21] HDAC6 as a therapeutic target in human breast cancer.
    Craig, Justin M.
    Schauwecker, Suzanne M.
    Clevenger, Charles V.
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 68 - 68
  • [22] HDAC6 expression is correlated with better survival in breast cancer
    Zhang, ZH
    Yamashita, H
    Toyama, T
    Sugiura, H
    Omoto, Y
    Ando, Y
    Mita, K
    Hamaguchi, M
    Hayashi, S
    Iwase, H
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6962 - 6968
  • [23] Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
    Preeti Putcha
    Jiyang Yu
    Ruth Rodriguez-Barrueco
    Laura Saucedo-Cuevas
    Patricia Villagrasa
    Eva Murga-Penas
    Steven N. Quayle
    Min Yang
    Veronica Castro
    David Llobet-Navas
    Daniel Birnbaum
    Pascal Finetti
    Wendy A. Woodward
    François Bertucci
    Mary L. Alpaugh
    Andrea Califano
    Jose Silva
    Breast Cancer Research, 19
  • [24] Invadopodia enable cooperative invasion and metastasis of breast cancer cells
    Louisiane Perrin
    Elizaveta Belova
    Battuya Bayarmagnai
    Erkan Tüzel
    Bojana Gligorijevic
    Communications Biology, 5
  • [25] HDAC6 INHIBITION SENSITIZES TUMOR CELLS TO ANTI-CD20 IMMUNOTHERAPY IN VIVO
    Bobrowicz, M.
    Dwojak, M.
    Stachura, J.
    Angelika, M.
    Beata, P.
    Marta, S.
    Miazek, N.
    Zapala, P.
    Golab, J.
    Winiarska, M.
    HAEMATOLOGICA, 2017, 102 : 568 - 568
  • [26] HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma
    Pham, Thao Q.
    Robinson, Kristin
    Xu, Lin
    Pavlova, Maria N.
    Skapek, Stephen X.
    Chen, Eleanor Y.
    ONCOGENE, 2021, 40 (03) : 578 - 591
  • [27] HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma
    Thao Q. Pham
    Kristin Robinson
    Lin Xu
    Maria N. Pavlova
    Stephen X. Skapek
    Eleanor Y. Chen
    Oncogene, 2021, 40 : 578 - 591
  • [28] Invadopodia enable cooperative invasion and metastasis of breast cancer cells
    Perrin, Louisiane
    Belova, Elizaveta
    Bayarmagnai, Battuya
    Tuezel, Erkan
    Gligorijevic, Bojana
    COMMUNICATIONS BIOLOGY, 2022, 5 (01) : 758
  • [29] Inhibition of HDAC6 activity in kidney diseases: a new perspective
    Ben Ke
    Yanxia Chen
    Wei Tu
    Ting Ye
    Xiangdong Fang
    Liping Yang
    Molecular Medicine, 2018, 24
  • [30] Inhibition of HDAC6 activity in kidney diseases: a new perspective
    Ke, Ben
    Chen, Yanxia
    Tu, Wei
    Ye, Ting
    Fang, Xiangdong
    Yang, Liping
    MOLECULAR MEDICINE, 2018, 24 : 1 - 6